Identification of a rapidly-spreading triple mutant for high-level
metabolic insecticide resistance in Anopheles gambiae provides a
real-time molecular diagnostic for anti-malarial intervention
deployment.
Abstract
Insecticide resistance provides both a pressing threat to the control of
vector-borne diseases and insights into the remarkable capacity of
natural populations to show rapid evolutionary responses. Malaria
control remains heavily dependent on deployment of insecticides,
primarily in long lasting insecticide treated nets (LLINs), but
resistance in the major malaria vectors has increased over the last 15
years. Identifying genetic mechanisms causing high-level resistance in
mosquitoes, which may almost entirely overcome pyrethroid efficacy, is
crucial for the development and deployment of potentially
resistance-breaking tools. Using the Anopheles gambiae 1000 genomes data
we identified a very recent selective sweep in Ugandan mosquitoes which
localized to a cluster of cytochrome P450 genes. Further interrogation
revealed a haplotype involving a trio of mutations, a point mutation in
Cyp6p4, an insertion of a partial Zanzibar transposable element (TE) and
a duplication of the Cyp6aa1 gene. The mutations appear to have
originated recently in An. gambiae from the Kenya-Uganda border region,
with stepwise replacement of the double-mutant (Zanzibar TE and
Cyp6p4-236M) with the triple-mutant haplotype (including Cyp6aa1
duplication), which has spread into the Democratic Republic of Congo and
Tanzania. The triple-mutant haplotype is strongly associated with
increased expression of genes able to metabolise pyrethroids; is
strongly predictive of resistance to pyrethroids but importantly,
appears less effective against LLINs co-treated with the synergist
piperonyl butoxide (PBO). Frequencies of the triple-mutant haplotype
remain spatially variable even within countries, suggesting an effective
marker system to guide deployment decisions for limited supplies of
PBO-pyrethroid co-treated LLINs across African countries.